ellipticine has been researched along with Cancer of Lung in 13 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The carbazole scaffold is an active structure showing anti-cancer biological activity, and the structural diversity has been expanded through the improvement and optimization of synthesizing methods." | 5.72 | Design, synthesis, and evaluation of 9-(pyrimidin-2-yl)-9H-carbazole derivatives disrupting mitochondrial homeostasis in human lung adenocarcinoma. ( Chen, YR; Li, KT; Ou, TM; Su, XX; Sun, JW; Wang, H; Wang, XN; Wu, JQ; Wu, XZ, 2022) |
| "The carbazole scaffold is an active structure showing anti-cancer biological activity, and the structural diversity has been expanded through the improvement and optimization of synthesizing methods." | 1.72 | Design, synthesis, and evaluation of 9-(pyrimidin-2-yl)-9H-carbazole derivatives disrupting mitochondrial homeostasis in human lung adenocarcinoma. ( Chen, YR; Li, KT; Ou, TM; Su, XX; Sun, JW; Wang, H; Wang, XN; Wu, JQ; Wu, XZ, 2022) |
| " This drug delivery system offers exciting possibilities for cancer therapy by increasing the bioavailability of anti-neoplastic drug to the tumor site." | 1.39 | Synthesis of poly-(3-hydroxybutyrate-co-12 mol % 3-hydroxyvalerate) by Bacillus cereus FB11: its characterization and application as a drug carrier. ( Ahmad, B; Chen, P; Hameed, A; Hasan, F; Masood, F; Yasin, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Ruckdeschel, JC | 1 |
| Modi, SP | 1 |
| el-Hamouly, W | 1 |
| Portuese, E | 1 |
| Archer, S | 1 |
| Devraj, R | 1 |
| Barrett, JF | 1 |
| Fernandez, JA | 1 |
| Katzenellenbogen, JA | 1 |
| Cushman, M | 1 |
| Scio, E | 1 |
| Ribeiro, A | 1 |
| Alves, TM | 1 |
| Romanha, AJ | 1 |
| Shin, YG | 1 |
| Cordell, GA | 1 |
| Zani, CL | 1 |
| Toviwek, B | 1 |
| Suphakun, P | 1 |
| Choowongkomon, K | 1 |
| Hannongbua, S | 1 |
| Gleeson, MP | 1 |
| Su, XX | 1 |
| Chen, YR | 1 |
| Wu, JQ | 1 |
| Wu, XZ | 1 |
| Li, KT | 1 |
| Wang, XN | 1 |
| Sun, JW | 1 |
| Wang, H | 1 |
| Ou, TM | 1 |
| Gębarowski, T | 1 |
| Wiatrak, B | 1 |
| Gębczak, K | 1 |
| Tylińska, B | 1 |
| Gąsiorowski, K | 1 |
| Masood, F | 1 |
| Chen, P | 3 |
| Yasin, T | 1 |
| Hasan, F | 1 |
| Ahmad, B | 1 |
| Hameed, A | 1 |
| Wang, JP | 1 |
| Yu, YC | 1 |
| Chen, SP | 2 |
| Liang, HC | 1 |
| Lin, CW | 2 |
| Fang, K | 2 |
| Zhang, L | 1 |
| Bennett, WF | 1 |
| Zheng, T | 1 |
| Ouyang, PK | 1 |
| Ouyang, X | 1 |
| Qiu, X | 1 |
| Luo, A | 1 |
| Karttunen, M | 1 |
| Cheng, WC | 1 |
| Huang, HT | 1 |
| Wu, Y | 1 |
| Sadatmousavi, P | 1 |
| Wang, R | 1 |
| Lu, S | 1 |
| Yuan, YF | 1 |
| Moody, TW | 1 |
| Czerwinski, G | 1 |
| Tarasova, NI | 1 |
| Moody, DL | 1 |
| Michejda, CJ | 1 |
| Keizer, HG | 1 |
| De Leeuw, SJ | 1 |
| Van Rijn, J | 1 |
| Pinedo, HM | 1 |
| Joenje, H | 1 |
13 other studies available for ellipticine and Cancer of Lung
| Article | Year |
|---|---|
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Ellipticines; Humans; Leukemia L1210; Lung N | 1992 |
Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Survival; Central Nerv | 1996 |
New bioactive coumarins from Kielmeyera albopunctata.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brazil; Chagas Disease; Clusiaceae; Coumarins; Humans; K | 2003 |
Synthesis and evaluation of the NSCLC anti-cancer activity and physical properties of 4-aryl-N-phenylpyrimidin-2-amines.
Topics: A549 Cells; Amines; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Pr | 2017 |
Design, synthesis, and evaluation of 9-(pyrimidin-2-yl)-9H-carbazole derivatives disrupting mitochondrial homeostasis in human lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Animals; Carbazoles; Carcinoma, Non-Small-Cell Lung; Homeostasis; Humans; Lu | 2022 |
Effect of new olivacine derivatives on p53 protein level.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; BALB 3T3 Cells; Cell Line, Tumor; Ellipticine | 2020 |
Synthesis of poly-(3-hydroxybutyrate-co-12 mol % 3-hydroxyvalerate) by Bacillus cereus FB11: its characterization and application as a drug carrier.
Topics: Antineoplastic Agents; Bacillus cereus; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Carri | 2013 |
The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Survival; Ellipticines; Gene | 2015 |
Effect of Cholesterol on Cellular Uptake of Cancer Drugs Pirarubicin and Ellipticine.
Topics: Animals; Antineoplastic Agents; Cell Membrane; Cells, Cultured; CHO Cells; Cholesterol; Cricetulus; | 2016 |
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells.
Topics: Active Transport, Cell Nucleus; Androstadienes; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cy | 2009 |
Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dr | 2012 |
The development of VIP-ellipticine conjugates.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Drug Design; Ellipticines; | 2004 |
Effect of artificial electron acceptors on the cytotoxicity of mitomycin C and doxorubicin in human lung tumor cells.
Topics: Carcinoma, Squamous Cell; Doxorubicin; Drug Interactions; Ellipticines; Humans; Lung Neoplasms; Meth | 1989 |